Argus
•
Sep 02, 2026
RMD: Lowering target price to $255.00
Summary
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
XRAY: What does Argus have to say about XRAY?
Sep 02, 2026
•
XRAY
TFX: Raising target price to $148.00
Sep 02, 2026
•
TFX
IDXX: Lowering target price to $600.00
Sep 02, 2026
•
IDXX
STE: Lowering target price to $253.00
Sep 02, 2026
•
STE
WAT: Lowering target price to $446.00
Sep 02, 2026
•
WAT
